TGen tests ultrasound as way to enhance cancer drug delivery

A Norwegian biotech company called Phoenix Solutions AS is working with the Translational Genomics Research Institute (TGen), a Phoenix, Arizona-based biomedical research facility, to test the use of these pulsed sound waves to direct and focus cancer drug therapies.

Go to Source

(Visited 7 times, 1 visits today)

Popular Posts